Luorui Shang
Union Hospital
Wuhan, 430022, China
Wuhan, 430022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Corrigendum to "Herba Patriniae and its component Isovitexin show anti-colorectal cancer effects by inducing apoptosis and cell-cycle arrest via p53 activation" [Biomed. Pharmacother., 168 (2023) 115690].
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 04, 2026
Research Progress of Sepsis and Nutrition: A Bibliometric and Visualized Analysis.
Journal: Journal of inflammation research
Published: June 19, 2026
Therapeutic potential and molecular mechanisms of Yi-Yi-Fu-Zi-Bai-Jiang-San in the treatment of colorectal cancer.
Journal: Frontiers in pharmacology
Published: February 25, 2026
Global Research Progress of Sepsis and Mitochondria: Bibliometrics and Visualized Analysis.
Journal: Current medicinal chemistry
Published: October 04, 2025
Targeting PANoptosis: a promising therapeutic strategy for ALI/ARDS.
Journal: Apoptosis : an international journal on programmed cell death
Published: August 19, 2025
Erianin reverses 5-FU resistance by targeting CALM1/CAMKK2 and activating autophagy in colorectal cancer.
Journal: Chemico-biological interactions
Published: June 23, 2025
Intestinal Fut2 deficiency exacerbated alcohol-related liver disease by disrupting nicotinamide metabolism.
Journal: Clinical and translational medicine
Published: May 16, 2025
Protective effects of Dachengqi Decoction in sepsis-associated liver injury based on network pharmacology analysis and experimental validation.
Journal: Journal of ethnopharmacology
Published: April 24, 2025
Ellagic acid mediated pyroptosis in hepatocellular carcinoma via the ESR1/G6PD pathway.
Journal: Biochemical pharmacology
Published: April 07, 2025
Macrophage pyroptosis and its crucial role in ALI/ARDS.
Journal: Frontiers in immunology
Published: November 19, 2024
Current status and trend of global research on the pharmacological effects of emodin family: bibliometric study and visual analysis.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: November 08, 2024
Corilagin inhibits human cytomegalovirus infection and replication via activating the cGAS-STING signaling pathway in vitro and in vivo.
Journal: International immunopharmacology
Published: September 13, 2024
Last Updated: 09/26/2026